Inventor

Ellen Laird

Inventor
Longmont, CO, US

Overview

28→
Patents
2000–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes17%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium14%
C07KPeptides7%
C07CAcyclic or carbocyclic compounds3%
C12NMicroorganisms or enzymes1%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
11,104,676Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases202110,730,8804,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors202010,189,8454,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors201910,017,482Mitotic kinesin inhibitors and methods of use thereof20189,499,503'Mitotic kinesin inhibitors and methods of use thereof'20169,221,841'Mitotic kinesin inhibitors and methods of use thereof'20159,102,639'Mitotic kinesin inhibitors and methods of use thereof'20158,962,596'5,7-substituted-imidazo[1,2-C]pyrimidines as inhibitors of JAK kinases'20158,623,895'Mitotic kinesin inhibitors and methods of use thereof'20148,580,828'Mitotic kinesin inhibitors and methods of use thereof'20138,394,795'Pyrazole [3, 4-B] pyridine Raf inhibitors'20138,338,452'Raf inhibitor compounds and methods of use thereof'20128,268,871'Mitotic kinesin inhibitors and methods of use thereof'20128,236,825'Mitotic kinesin inhibitors and methods of use thereof'20128,044,083'Kinase inhibitors and methods of use thereof'20118,039,639'Kinase inhibitors and methods of use thereof'20117,956,073'Mitotic kinesin inhibitors and methods of use thereof'20117,795,282'Mitotic kinesin inhibitors and methods of use thereof'20107,732,446'Dipeptidyl peptidase inhibitors'20107,566,716'Imidazopyrazines as Raf inhibitor compounds'20097,491,829'RAF inhibitor compounds and methods'20097,449,486'Mitotic kinesin inhibitors and methods of use thereof'20087,351,825'Cyclopropane compounds and pharmaceutical use thereof'20086,696,464'Triazolo-pyridines anti-inflammatory compounds'20046,664,395'Benzotriazoles anti-inflammatory compounds'20036,458,822'2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases'20026,251,620'Three dimensional structure of a ZAP tyrosine protein kinase fragment and modeling methods'20016,114,361'5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2002Based in Mystic, CT, US· patent location history
2001Based in Newton, MA, US· patent location history
2003–2014Based in Longmont, CO, US· patent location history
2008–2021Patents assigned to ARRAY BIOPHARMA INC (21)· patent assignee history
2011–2021Based in Boulder, CO, US· patent location history
2012–2015Patents assigned to ZHAO QIAN (5)· patent assignee history
2012–2014Patents assigned to ALLEN SHELLEY (4)· patent assignee history
2012–2014Patents assigned to HANS JEREMY (4)· patent assignee history
2012–2014Patents assigned to LAIRD ELLEN R (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ARRAY BIOPHARMA INC212008–2021
ZHAO QIAN52012–2015
ALLEN SHELLEY42012–2014
HANS JEREMY42012–2014
LAIRD ELLEN Rself42012–2014
Locations
LocationPatentsSpan
Longmont, CO, US142003–2014
Boulder, CO, US112011–2021
Mystic, CT, US22000–2002
Newton, Massachusetts, US12001